1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > EU Drugs for Melanoma Treatment Industry 2015 Market Research Report

EU Drugs for Melanoma Treatment Industry 2015 Market Research Report

  • November 2015
  • -
  • QY Research Group
  • -
  • 131 pages

Summary


The EU Drugs for Melanoma Treatment Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Drugs for Melanoma Treatment industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Drugs for Melanoma Treatment market analysis is provided for the EU markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on EU major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Drugs for Melanoma Treatment industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 151 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

EU Drugs for Melanoma Treatment Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Drugs for Melanoma Treatment
1.2 Classification of Drugs for Melanoma Treatment
1.3 Applications of Drugs for Melanoma Treatment
1.4 Industry Chain Structure of Drugs for Melanoma Treatment
1.5 Industry Overview of Drugs for Melanoma Treatment
1.6 Industry Policy Analysis of Drugs for Melanoma Treatment
1.7 Industry News Analysis of Drugs for Melanoma Treatment

2 Manufacturing Cost Structure Analysis of Drugs for Melanoma Treatment
2.1 Bill of Materials (BOM) of Drugs for Melanoma Treatment
2.2 BOM Price Analysis of Drugs for Melanoma Treatment
2.3 Labor Cost Analysis of Drugs for Melanoma Treatment
2.4 Depreciation Cost Analysis of Drugs for Melanoma Treatment
2.5 Manufacturing Cost Structure Analysis of Drugs for Melanoma Treatment
2.6 Manufacturing Process Analysis of Drugs for Melanoma Treatment
2.7 China Price, Cost and Gross of Drugs for Melanoma Treatment 2010-2015

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of EU Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of EU Key Drugs for Melanoma Treatment Manufacturers in 2014
3.3 RandD Status and Technology Source of EU Drugs for Melanoma Treatment Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of EU Drugs for Melanoma Treatment Key Manufacturers in 2014

4 Production Analysis of Drugs for Melanoma Treatment by Regions, Type, and Applications
4.1 EU Production of Drugs for Melanoma Treatment by Regions 2010-2015
4.2 EU Production of Drugs for Melanoma Treatment by Type 2010-2015
4.3 EU Sales of Drugs for Melanoma Treatment by Applications 2010-2015
4.4 Price Analysis of EU Drugs for Melanoma Treatment Key Manufacturers in 2015
4.5 EU Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Drugs for Melanoma Treatment 2010-2015

5 Consumption Volume and Consumption Value Analysis of Drugs for Melanoma Treatment by Regions
5.1 EU Consumption Volume of Drugs for Melanoma Treatment by Regions 2010-2015
5.2 EU Consumption Value of Drugs for Melanoma Treatment by Regions 2010-2015
5.3 EU Consumption Price Analysis of Drugs for Melanoma Treatment by Regions 2010-2015

6 Analysis of Drugs for Melanoma Treatment Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity, Production, Sales, and Revenue of Drugs for Melanoma Treatment 2010-2015
6.2 Production Market Share and Sales Market Share Analysis of Drugs for Melanoma Treatment 2014-2015
6.3 Sales Overview of Drugs for Melanoma Treatment 2010-2015
6.4 Supply, Consumption and Gap of Drugs for Melanoma Treatment 2010-2015
6.5 Import, Export and Consumption of Drugs for Melanoma Treatment 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Drugs for Melanoma Treatment 2010-2015

7 Analysis of Drugs for Melanoma Treatment Industry Key Manufacturers
7.1 AB Science
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 AB Science SWOT Analysis

7.2 Amgen
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Amgen SWOT Analysis

7.3 Bristol-Myers Squibb
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Bristol-Myers Squibb SWOT Analysis

7.4 Celgene
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Celgene SWOT Analysis

7.5 Eisai
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Eisai SWOT Analysis

7.6 Roche
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 Roche SWOT Analysis

7.7 GlaxoSmithKline?GSK?
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 GlaxoSmithKline?GSK? SWOT Analysis

7.8 Novartis
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Novartis SWOT Analysis

7.9 Vical
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 Vical SWOT Analysis

8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Drugs for Melanoma Treatment Product Types
8.5 Market Share Analysis of Different Drugs for Melanoma Treatment Price Levels
8.6 Gross Margin Analysis of Different Drugs for Melanoma Treatment Applications

9 Marketing Trader or Distributor Analysis of Drugs for Melanoma Treatment
9.1 Marketing Channels Status of Drugs for Melanoma Treatment
9.2 Traders or Distributors of Drugs for Melanoma Treatment with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Drugs for Melanoma Treatment
9.4 EU Import, Export and Trade Analysis of Drugs for Melanoma Treatment

10 Development Trend of Drugs for Melanoma Treatment Industry 2016-2021
10.1 Capacity and Production Overview of Drugs for Melanoma Treatment 2016-2021
10.2 Production Market Share by Product Types of Drugs for Melanoma Treatment 2016-2021
10.3 Sales and Sales Revenue Overview of Drugs for Melanoma Treatment 2016-2021
10.4 EU Sales of Drugs for Melanoma Treatment by Applications 2016-2021
10.5 Import, Export and Consumption of Drugs for Melanoma Treatment 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Drugs for Melanoma Treatment 2016-2021

11 Industry Chain Suppliers of Drugs for Melanoma Treatment with Contact Information
11.1 Major Raw Materials Suppliers of Drugs for Melanoma Treatment with Contact Information
11.2 Manufacturing Equipment Suppliers of Drugs for Melanoma Treatment with Contact Information
11.3 Major Players of Drugs for Melanoma Treatment with Contact Information
11.4 Key Consumers of Drugs for Melanoma Treatment with Contact Information
11.5 Supply Chain Relationship Analysis of Drugs for Melanoma Treatment

12 New Project Investment Feasibility Analysis of Drugs for Melanoma Treatment
12.1 New Project SWOT Analysis of Drugs for Melanoma Treatment
12.2 New Project Investment Feasibility Analysis of Drugs for Melanoma Treatment

13 Conclusion of the EU Drugs for Melanoma Treatment Industry 2015 Market Research Report




List of Tables and Figures

Figure Picture of Drugs for Melanoma Treatment
Table Product Specifications of Drugs for Melanoma Treatment
Table Classification of Drugs for Melanoma Treatment
Figure EU Sales Market Share of Drugs for Melanoma Treatment by Product Types in 2014
Table Applications of Drugs for Melanoma Treatment
Figure EU Sales Market Share of Drugs for Melanoma Treatment by Applications in 2014
Figure Industry Chain Structure of Drugs for Melanoma Treatment
Table EU Industry Overview of Drugs for Melanoma Treatment
Table Industry Policy of Drugs for Melanoma Treatment
Table Industry News List of Drugs for Melanoma Treatment
Table Bill of Materials (BOM) of Drugs for Melanoma Treatment
Table Bill of Materials (BOM) Price of Drugs for Melanoma Treatment
Table Labor Cost of Drugs for Melanoma Treatment
Table Depreciation Cost of Drugs for Melanoma Treatment
Table Manufacturing Cost Structure Analysis of Drugs for Melanoma Treatment in 2014
Figure Manufacturing Process Analysis of Drugs for Melanoma Treatment
Table EU Price Analysis of Drugs for Melanoma Treatment 2010-2015 (USD/MT)
Table EU Cost Analysis of Drugs for Melanoma Treatment 2010-2015 (USD/MT)
Table EU Gross Analysis of Drugs for Melanoma Treatment 2010-2015
Table Capacity (K MT) and Commercial Production Date of EU Drugs for Melanoma Treatment Key Manufacturers in 2014
Table Manufacturing Plants Distribution of EU Key Drugs for Melanoma Treatment Manufacturers in 2014
Table RandD Status and Technology Source of EU Drugs for Melanoma Treatment Key Manufacturers in 2014
Table Raw Materials Sources Analysis of EU and EU Drugs for Melanoma Treatment Key Manufacturers in 2014
Table EU Production of Drugs for Melanoma Treatment by Regions 2010-2015 (K MT)
Table EU Production Market Share of Drugs for Melanoma Treatment by Regions 2010-2015
Figure EU Production Market Share of Drugs for Melanoma Treatment by Regions in 2014
Figure EU Production Market Share of Drugs for Melanoma Treatment by Regions in 2015
Table EU Production of Drugs for Melanoma Treatment by Types in 2010-2015 (K MT)
Table EU Production Market Share of Drugs for Melanoma Treatment by Type in 2010-2015
Figure EU Production Market Share of Drugs for Melanoma Treatment by Type in 2014
Figure EU Production Market Share of Drugs for Melanoma Treatment by Type in 2015
Table EU Sales of Drugs for Melanoma Treatment by Applications 2010-2015 (K MT)
Table EU Production Market Share of Drugs for Melanoma Treatment by Applications 2010-2015
Figure EU Production Market Share of Drugs for Melanoma Treatment by Applications in 2014
Figure EU Production Market Share of Drugs for Melanoma Treatment by Applications in 2015
Table Price Comparison of EU Drugs for Melanoma Treatment Key Manufacturers in 2015 (USD/MT)
Table EU Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Drugs for Melanoma Treatment 2010-2015
Table EU Consumption Volume of Drugs for Melanoma Treatment by Regions 2010-2015 (K MT)
Table EU Consumption Volume Market Share of Drugs for Melanoma Treatment by Regions 2010-2015 (%)
Figure EU Consumption Volume Market Share of Drugs for Melanoma Treatment by Regions in 2014
Figure EU Consumption Volume Market Share of Drugs for Melanoma Treatment by Regions in 2015
Table EU Consumption Value of Drugs for Melanoma Treatment by Regions 2010-2015 (M USD)
Table EU Consumption Value Market Share of Drugs for Melanoma Treatment by Regions 2010-2015
Figure EU Consumption Value Market Share of Drugs for Melanoma Treatment by Regions in 2014
Figure EU Consumption Value Market Share of Drugs for Melanoma Treatment by Regions in 2015
Table Consumption Price of Drugs for Melanoma Treatment by Regions 2010-2015 (USD/MT)
Table EU and Major Manufacturers Capacity of Drugs for Melanoma Treatment 2010-2015 (K MT)
Table EU Capacity Market Share of Major Drugs for Melanoma Treatment Manufacturers 2010-2015
Table EU and Major Manufacturers Production of Drugs for Melanoma Treatment 2010-2015 (K MT)
Table EU Production Market Share of Major Drugs for Melanoma Treatment Manufacturers 2010-2015
Table EU and Major Manufacturers Sales of Drugs for Melanoma Treatment 2010-2015 (K MT)
Table EU Sales Market Share of Major Drugs for Melanoma Treatment Manufacturers 2010-2015
Table EU and Major Manufacturers Sales Revenue of Drugs for Melanoma Treatment 2010-2015 (M USD)
Table EU Sales Revenue Market Share of Major Drugs for Melanoma Treatment Manufacturers 2010-2015
Figure EU Capacity (K MT), Production (K MT) and Growth Rate of Drugs for Melanoma Treatment 2010-2015
Figure EU Capacity Utilization Rate of Drugs for Melanoma Treatment 2010-2015
Figure EU Sales Revenue (M USD) and Growth Rate of Drugs for Melanoma Treatment 2010-2015
Figure EU Production Market Share of Major Drugs for Melanoma Treatment Manufacturers in 2014
Figure EU Production Market Share of Major Drugs for Melanoma Treatment Manufacturers in 2015
Figure EU Sales Market Share of Major Drugs for Melanoma Treatment Manufacturers in 2014
Figure EU Sales Market Share of Major Drugs for Melanoma Treatment Manufacturers in 2015
Figure EU Sales (K MT) and Growth Rate of Drugs for Melanoma Treatment 2010-2015
Table EU Supply, Consumption and Gap of Drugs for Melanoma Treatment 2010-2015 (K MT)
Table EU Import, Export and Consumption of Drugs for Melanoma Treatment 2010-2015 (K MT)
Table Price of EU Drugs for Melanoma Treatment Major Manufacturers 2010-2015 (USD/MT)
Table Gross Margin of EU Drugs for Melanoma Treatment Major Manufacturers 2010-2015
Table EU and Major Manufacturers Revenue of Drugs for Melanoma Treatment 2010-2015 (M USD)
Table EU Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Revenue (M USD) and Gross Margin of Drugs for Melanoma Treatment 2010-2015
Table AB Science Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Melanoma Treatment Picture and Specifications of AB Science
Table Drugs for Melanoma Treatment Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of AB Science 2010-2015
Figure Drugs for Melanoma Treatment Capacity (K MT), Production (K MT) and Growth Rate of AB Science 2010-2015
Figure Drugs for Melanoma Treatment Production (K MT) and EU Market Share of AB Science 2010-2015
Table AB Science Drugs for Melanoma Treatment SWOT Analysis
Table Amgen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Melanoma Treatment Picture and Specifications of Amgen
Table Drugs for Melanoma Treatment Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Amgen 2010-2015
Figure Drugs for Melanoma Treatment Capacity (K MT), Production (K MT) and Growth Rate of Amgen 2010-2015
Figure Drugs for Melanoma Treatment Production (K MT) and EU Market Share of Amgen 2010-2015
Table Amgen Drugs for Melanoma Treatment SWOT Analysis
Table Bristol-Myers Squibb Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Melanoma Treatment Picture and Specifications of Bristol-Myers Squibb
Table Drugs for Melanoma Treatment Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb 2010-2015
Figure Drugs for Melanoma Treatment Capacity (K MT), Production (K MT) and Growth Rate of Bristol-Myers Squibb 2010-2015
Figure Drugs for Melanoma Treatment Production (K MT) and EU Market Share of Bristol-Myers Squibb 2010-2015
Table Bristol-Myers Squibb Drugs for Melanoma Treatment SWOT Analysis
Table Celgene Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Melanoma Treatment Picture and Specifications of Celgene
Table Drugs for Melanoma Treatment Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Celgene 2010-2015
Figure Drugs for Melanoma Treatment Capacity (K MT), Production (K MT) and Growth Rate of Celgene 2010-2015
Figure Drugs for Melanoma Treatment Production (K MT) and EU Market Share of Celgene 2010-2015
Table Celgene Drugs for Melanoma Treatment SWOT Analysis
Table Eisai Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Melanoma Treatment Picture and Specifications of Eisai
Table Drugs for Melanoma Treatment Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Eisai 2010-2015
Figure Drugs for Melanoma Treatment Capacity (K MT), Production (K MT) and Growth Rate of Eisai 2010-2015
Figure Drugs for Melanoma Treatment Production (K MT) and EU Market Share of Eisai 2010-2015
Table Eisai Drugs for Melanoma Treatment SWOT Analysis
Table Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Melanoma Treatment Picture and Specifications of Roche
Table Drugs for Melanoma Treatment Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Roche 2010-2015
Figure Drugs for Melanoma Treatment Capacity (K MT), Production (K MT) and Growth Rate of Roche 2010-2015
Figure Drugs for Melanoma Treatment Production (K MT) and EU Market Share of Roche 2010-2015
Table Roche Drugs for Melanoma Treatment SWOT Analysis
Table GlaxoSmithKline?GSK? Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Melanoma Treatment Picture and Specifications of GlaxoSmithKline?GSK?
Table Drugs for Melanoma Treatment Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of GlaxoSmithKline?GSK? 2010-2015
Figure Drugs for Melanoma Treatment Capacity (K MT), Production (K MT) and Growth Rate of GlaxoSmithKline?GSK? 2010-2015
Figure Drugs for Melanoma Treatment Production (K MT) and EU Market Share of GlaxoSmithKline?GSK? 2010-2015
Table GlaxoSmithKline?GSK? Drugs for Melanoma Treatment SWOT Analysis
Table Novartis Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Melanoma Treatment Picture and Specifications of Novartis
Table Drugs for Melanoma Treatment Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Novartis 2010-2015
Figure Drugs for Melanoma Treatment Capacity (K MT), Production (K MT) and Growth Rate of Novartis 2010-2015
Figure Drugs for Melanoma Treatment Production (K MT) and EU Market Share of Novartis 2010-2015
Table Novartis Drugs for Melanoma Treatment SWOT Analysis
Table Vical Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Melanoma Treatment Picture and Specifications of Vical
Table Drugs for Melanoma Treatment Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Vical 2010-2015
Figure Drugs for Melanoma Treatment Capacity (K MT), Production (K MT) and Growth Rate of Vical 2010-2015
Figure Drugs for Melanoma Treatment Production (K MT) and EU Market Share of Vical 2010-2015
Table Vical Drugs for Melanoma Treatment SWOT Analysis
Table Drugs for Melanoma Treatment Price by Regions 2010-2015
Table Drugs for Melanoma Treatment Price by Product Types 2010-2015
Table Drugs for Melanoma Treatment Price by Companies 2010-2015
Table Drugs for Melanoma Treatment Gross Margin by Companies 2010-2015
Table Price Comparison of Drugs for Melanoma Treatment by Regions 2010-2015 (USD/MT)
Table Price of Different Drugs for Melanoma Treatment Product Types (USD/MT)
Table Market Share of Different Drugs for Melanoma Treatment Price Level
Table Gross Margin of Different Drugs for Melanoma Treatment Applications
Table Marketing Channels Status of Drugs for Melanoma Treatment
Table Traders or Distributors of Drugs for Melanoma Treatment with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Drugs for Melanoma Treatment (USD/MT) in 2015
Table EU Import, Export, and Trade of Drugs for Melanoma Treatment (K MT)
Figure EU Capacity (K MT), Production (K MT) and Growth Rate of Drugs for Melanoma Treatment 2016-2021
Figure EU Capacity Utilization Rate of Drugs for Melanoma Treatment 2016-2021
Table EU Drugs for Melanoma Treatment Production by Type 2016-2021 (K MT)
Table EU Drugs for Melanoma Treatment Production Market Share by Type 2016-2021
Figure EU Production Market Share of Drugs for Melanoma Treatment by Type in 2021
Figure EU Sales (K MT) and Growth Rate of Drugs for Melanoma Treatment 2016-2021
Figure EU Sales Revenue (Million USD) and Growth Rate of Drugs for Melanoma Treatment 2016-2021
Figure EU Sales of Drugs for Melanoma Treatment by Applications 2016-2021 (K MT)
Table EU Production Market Share of Drugs for Melanoma Treatment by Applications 2016-2021
Figure EU Production Market Share of Drugs for Melanoma Treatment by Applications in 2021
Table EU Production, Import, Export and Consumption of Drugs for Melanoma Treatment 2016-2021 (K MT)
Table EU Production (K MT), Price (USD/MT), Cost (USD/MT), Revenue (M USD) and Gross Margin of Drugs for Melanoma Treatment 2016-2021
Table Major Raw Materials Suppliers of Drugs for Melanoma Treatment with Contact Information
Table Manufacturing Equipment Suppliers of Drugs for Melanoma Treatment with Contact Information
Table Major Players of Drugs for Melanoma Treatment with Contact Information
Table Key Consumers of Drugs for Melanoma Treatment with Contact Information
Table Supply Chain Relationship Analysis of Drugs for Melanoma Treatment
Table New Project SWOT Analysis of Drugs for Melanoma Treatment
Table New Project Investment Feasibility Analysis of Drugs for Melanoma Treatment
Table Part of Interviewees Record List

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
TCR/CAR-T Therapies in Oncology: Analytical Tool

TCR/CAR-T Therapies in Oncology: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The nuclear medicine/radiopharmaceuticals market is projected to reach USD 7.27 billion by 2021 from USD 4.67 billion in 2016, growing at a CAGR of 9.3% in the next five years (2016 to 2021). Over the ...

Tumor Ablation Market by Technology, Mode of Treatment, Application - Global Forecast 2021

Tumor Ablation Market by Technology, Mode of Treatment, Application - Global Forecast 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global tumor ablation market is estimated to register a high CAGR of 12.5% during 2016-2021, and is expected to be valued at ~USD 580.1 million in 2021. Although mature markets (North America and Europe) ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.